Is Primary Aldosteronism Genetic or Hereditary? Family Risk
At a Glance
Most primary aldosteronism is not hereditary because it usually results from changes limited to adrenal cells. Only about 1% to 6% is linked to inherited Familial Hyperaldosteronism; genetic counseling and family testing may be appropriate in selected cases.
In this answer
3 sections
It is completely understandable to worry about your children’s health after receiving a primary aldosteronism diagnosis. The reassuring news is that for the vast majority of people, primary aldosteronism is not hereditary. It is most often caused by sporadic issues that cannot be passed on to your children [1][2]. However, a very small percentage of cases (roughly 1% to 6%) are caused by inherited genetic traits, known collectively as Familial Hyperaldosteronism [3][4].
Understanding the difference between the common non-inherited forms and the rare inherited forms can help you make informed decisions about your family’s care.
Somatic vs. Germline Mutations
To understand why most cases are not hereditary, it helps to know the difference between two types of genetic mutations:
- Somatic Mutations (Not Inherited): Many cases of primary aldosteronism involve aldosterone-producing adenomas (benign, non-cancerous tumors) or overactive clusters of cells in the adrenal glands. In 80% to 90% of these specific adenomas, researchers find a mutation that happened spontaneously within the adrenal cells [1][2]. These are called somatic mutations. They cause the adrenal gland to overproduce aldosterone, a hormone that raises blood pressure by making the kidneys retain salt and water [5][6]. Because these mutations are confined strictly to the adrenal tissue and are not in your reproductive cells, they cannot be passed to your children [1][7]. Not every patient with primary aldosteronism has an adenoma or an identifiable mutation, but the vast majority of cases are still non-inherited.
- Germline Mutations (Inherited): In rare cases, a genetic mutation is present in every cell of the body from birth, meaning it can be passed from parent to child [3][2]. When primary aldosteronism is caused by a germline mutation, it is called Familial Hyperaldosteronism (FH). There are several recognized types of FH (Types I, II, III, and IV), each tied to a different inherited gene [3][8]. Most of these recognized familial forms are inherited in an autosomal dominant pattern, which means each biological child of a person with the mutation has a 50% (1 in 2) chance of inheriting it, though the severity of the disease can vary.
When to Suspect an Inherited Form
Because Familial Hyperaldosteronism is rare, routine genetic testing is not automatically recommended for everyone with primary aldosteronism. However, you should discuss genetic testing with your doctor if:
- You were diagnosed with primary aldosteronism at a young age, particularly before the age of 20 [9][10].
- You have a strong family history of primary aldosteronism [9][11].
- You or your first-degree relatives (parents, siblings, or children) have a family history of early-onset strokes or other cerebrovascular events before age 40 [9][12].
If you undergo a genetic panel and the results are negative, it usually means no currently detectable cause was found, though it does not completely rule out all inherited susceptibility [13][14].
Should Your Children Get Tested?
If your doctor determines that your primary aldosteronism is the standard, sporadic type, there is no need for your children to undergo genetic testing for the disease [15][16]. Regular blood pressure checks at routine pediatric visits are sufficient.
If you undergo genetic testing and are diagnosed with a confirmed inherited form of Familial Hyperaldosteronism, your medical team will likely recommend cascade screening [15][16]. This involves working with a genetic counselor to offer targeted testing to your first-degree relatives to see if they carry the specific family mutation. Identifying the mutation early allows doctors to monitor them proactively [15][16].
Blood Tests and Blood Pressure Monitoring
Even without a confirmed genetic link, it is practical to ensure your close family members have their blood pressure checked regularly. However, routine biochemical testing is not recommended for relatives who have normal blood pressure.
If a child or family member develops high blood pressure—especially if it is severe, resistant to medications, or starts at a young age—they should receive a timely medical evaluation. Clinicians will typically screen for the disease using the aldosterone-to-renin ratio (ARR) [9][17][18].
Important notes about the ARR test:
- The ARR is a screening blood test that compares the levels of aldosterone and renin in the blood.
- The results can be heavily influenced by blood pressure medications, salt intake, and potassium levels [18][19]. You should never stop or change medications before the test without direct medical advice.
- For children, interpreting the ARR requires specialized pediatric endocrinology expertise because normal hormone levels change with age.
- Keep in mind that normal potassium levels do not rule out primary aldosteronism; many people with the condition have normal potassium [20][12].
Common questions in this guide
Is primary aldosteronism usually inherited?
What is the chance that my child will inherit Familial Hyperaldosteronism?
When should someone with primary aldosteronism consider genetic testing?
Do my children need genetic testing if I have primary aldosteronism?
How are relatives screened for primary aldosteronism?
What does a negative genetic test for Familial Hyperaldosteronism mean?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Genetic testing
Should I ask my doctor about genetic testing for primary aldosteronism?
Children's testing
Would my children need genetic testing, or only regular blood pressure checks, for primary aldosteronism?
Family screening
What would cascade screening involve for my first-degree relatives?
Related questions
Show more
Get notified when new evidence is published on hyperaldosteronism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
Nanba K, Omata K, Else T, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(10)):3869-3876 doi:10.1210/jc.2018-01004.
PMID: 30085035 - 2
Genetics of Primary Aldosteronism.
Scholl UI
Hypertension (Dallas, Tex. : 1979) 2022; (79(5)):887-897 doi:10.1161/HYPERTENSIONAHA.121.16498.
PMID: 35139664 - 3
Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome.
Vaduva P, Bonnet F, Bertherat J
Journal of the Endocrine Society 2020; (4(9)):bvaa075 doi:10.1210/jendso/bvaa075.
PMID: 32783015 - 4
An Update on Familial Hyperaldosteronism.
Korah HE, Scholl UI
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2015; (47(13)):941-6 doi:10.1055/s-0035-1564166.
PMID: 26445452 - 5
[Primary aldosteronism : Genetics and pathology].
Scholl U
Der Pathologe 2019; (40(Suppl 3)):369-372 doi:10.1007/s00292-019-00682-x.
PMID: 31705237 - 6
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Pitsava G, Faucz FR, Stratakis CA, Hannah-Shmouni F
Current cardiology reports 2022; (24(9)):1189-1195 doi:10.1007/s11886-022-01735-z.
PMID: 35841527 - 7
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.
Nishimoto K, Tomlins SA, Kuick R, et al.
Proceedings of the National Academy of Sciences of the United States of America 2015; (112(33)):E4591-9 doi:10.1073/pnas.1505529112.
PMID: 26240369 - 8
Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels.
Stowasser M, Wolley M, Wu A, et al.
Current hypertension reports 2019; (21(4)):31 doi:10.1007/s11906-019-0934-y.
PMID: 30949771 - 9
Genetic testing for familial hyperaldosteronism type 1 in Aotearoa/New Zealand.
Elston MS, Tamatea JAU, King RI, et al.
Internal medicine journal 2024; (54(11)):1814-1820 doi:10.1111/imj.16511.
PMID: 39215608 - 10
[Primary aldosteronism: new insights into familial forms].
van den Meiracker AH, van der Linde AA, Claahsen van der Grinten HL, et al.
Nederlands tijdschrift voor geneeskunde 2015; (159()):A8932.
PMID: 26420144 - 11
Primary Hyperaldosteronism: Epidemiology, Diagnosis, and Clinical Associations.
Savvidis C, Milionis C, Pachi A, et al.
Epidemiologia (Basel, Switzerland) 2026; (7(2)) doi:10.3390/epidemiologia7020032.
PMID: 41873981 - 12
A Chinese pedigree with glucocorticoid remediable aldosteronism.
Liu X, Jin L, Zhang H, et al.
Hypertension research : official journal of the Japanese Society of Hypertension 2021; (44(11)):1428-1433 doi:10.1038/s41440-021-00685-3.
PMID: 34462604 - 13
New mutation of CACNA1H p.Tyr613Phe in hyperaldosteronism: a case report.
Yan Q, Qu X, Wang R, et al.
Frontiers in medicine 2025; (12()):1715935 doi:10.3389/fmed.2025.1715935.
PMID: 41601799 - 14
Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.
Maria AG, Suzuki M, Berthon A, et al.
American journal of hypertension 2020; (33(2)):124-130 doi:10.1093/ajh/hpz172.
PMID: 31637427 - 15
Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline.
Mulatero P, Scholl UI, Fardella CE, et al.
European journal of endocrinology 2024; (190(4)):G1-G14 doi:10.1093/ejendo/lvae041.
PMID: 38571460 - 16
Familial Hyperaldosteronism Type IV (FH-IV)-Clinical Phenotypes, Genetics and Management of CACNA1H-Related Primary Aldosteronism: A Systematic Review.
Michalski W, Jaszczyszyn I, Bielska W, Stolarczyk A
Journal of clinical medicine 2026; (15(10)) doi:10.3390/jcm15103693.
PMID: 42194655 - 17
Primary aldosteronism diagnosis in the intensive care unit: resistant alkalosis and hypokalemia during severe sepsis with hyperlactatemia: a case report.
Garg Y, Vaishnav MS, Harsha R, et al.
Journal of medical case reports 2025; (19(1)):192 doi:10.1186/s13256-025-05112-6.
PMID: 40281610 - 18
Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care.
Ariens J, Horvath AR, Yang J, Choy KW
Endocrine 2022; (77(1)):11-20 doi:10.1007/s12020-022-03084-x.
PMID: 35622194 - 19
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
Douillard C, Houillier P, Nussberger J, Girerd X
Annales d'endocrinologie 2016; (77(3)):192-201.
PMID: 27177498 - 20
What We Know about and What Is New in Primary Aldosteronism.
Ekman N, Grossman AB, Dworakowska D
International journal of molecular sciences 2024; (25(2)) doi:10.3390/ijms25020900.
PMID: 38255973
This page provides general information about hereditary risk in primary aldosteronism for educational purposes only and does not constitute medical advice. Discuss genetic testing and family screening with your endocrinologist or a genetic counselor.